Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease.

Bhatia, Shiveena; Singh, Manjinder; Singh, Tanveer; Singh, Varinder

Bhatia, Shiveena; Singh, Manjinder; Singh, Tanveer; Singh, Varinder.

Afiliación

Bhatia S; Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Singh M; Chitkara College of Pharmacy, Chitkara University, Punjab, India. manjinder.singh@chitkara.edu.in.
Singh T; Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A &M University Health Science Centre, Bryan, TX, 77807, USA.
Singh V; Chitkara College of Pharmacy, Chitkara University, Punjab, India. varinderjassal17@gmail.com.

Neurochem Res ; 48(1): 13-25, 2023 Jan.

Article en En | MEDLINE | ID: mdl-35987974

Asunto(s)

Enfermedad de Alzheimer; Neoplasias; Humanos; Enfermedad de Alzheimer/metabolismo; Quimera Dirigida a la Proteólisis; Proteínas/metabolismo; Proteolisis; Ubiquitina-Proteína Ligasas/metabolismo

Palabras clave

Alzheimer's disease; Dementia; Neurodegenerative disorders; PROTACs; Protein degradation; UPS machinery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Neoplasias Límite: Humans Idioma: En Revista: Neurochem Res Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google